Correction to: Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients

J Immunother Cancer. 2019 Jan 11;7(1):9. doi: 10.1186/s40425-018-0487-7.

Authors

Bin Zhao¹, Hong Zhao², Jiaxin Zhao³

Affiliations

¹ The Second Affiliated Hospital & Yuying Children's Hospital, Wenzhou Medical University, Wenzhou, China. [email protected].
² The Third Affiliated Hospital of Harbin Medical University, Harbin, China. [email protected].
³ The Fourth Affiliated Hospital of Harbin Medical University, Harbin, China. [email protected].

Abstract

Following publication of the original article [1], the authors reported an error in their listed affiliations.

Publication types

Published Erratum